Search clinical trials for: Moderately-Hypo-fractionation Radiotherapy

Total 39 results

Vanderbilt-Ingram Cancer Center

Recruiting

Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas

Soft Tissue Sarcomas

United States
Tata Memorial Centre
Tata Medical Center

Recruiting

Prostate Radiotherapy Comparing Moderate and Extreme Hypo-fractionation (PRIME Trial) (PRIME)

Prostate Adenocarcinoma

India
Umeå University

Recruiting

Different Fractionation Schedules of Radiotherapy to the Primary Tumour in Metastatic Hormone Sensitive Prostate Cancer (Hypo-M1)

Prostate Cancer | Metastatic Cancer | Radiotherapy Side Effect

Sweden
Sohag University

Recruiting

One Week Adjuvant Radiotherapy for Breast Cancer

Breast Carcinoma

Egypt
University of Kansas Medical Center

Recruiting

Comparing Hypo-fractionated Intensity- Modulated Radiation Therapy to Standard- Fractionated IMRT Along With Chemotherapy and Immunotherapy for Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer Stage

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Use of a Proliferation Saturation Index to Determine Personalized Radiotherapy for HPV + Oropharyngeal Cancers

Oropharyngeal Cancer

United States
Cancer Institute and Hospital, Chinese Academy...

Completed

A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cancer

Breast Cancer

China
The Netherlands Cancer Institute
Radboud University Medical Center; Universitaire Ziekenhuizen KU Leuven

Recruiting

Standard Moderately Hypofractionated RT vs. Ultra-hypofractionated Focal Lesion Ablative Microboost in Prostate Cancer

Prostate Cancer

Netherlands
St George Hospital, Australia

Completed

Brain Metastases Study: Radiotherapy Fractionation Schemes in the Treatment of Brain Metastases

Neoplasm Metastasis | Brain Neoplasms

Australia
Stanford University

Completed

Hypofractionated Radiotherapy for Localized Prostate Cancer (With CyberKnife or With IMRT)

Prostatic Neoplasms

United States
International Atomic Energy Agency

Completed

Trial of Five Versus Six Fractions Per Week for Head and Neck Cancer

Head and Neck Cancer
Assistance Publique - Hôpitaux de Paris

Recruiting

Impact of Hypofractionated Radiotherapy Strategy After Surgery of Skin Carcinomas in Older Patients (IMPACTE-01)

Skin Cancer, Non-Melanoma

France
Cancer Institute and Hospital, Chinese Academy...

Unknown

Study of Hypo-fractionated Neoadjuvant Radiotherapy for Locally Advanced Gastric Cancer

Gastric Cancer | Chemoradiation

China
Royal North Shore Hospital

Recruiting

Breast Fractionation Study - Standard Versus Investigational Fractionation Trial - Nodal Radiation

Breast Cancer | Post Mastectomy

Australia
Tata Medical Center

Completed

Hypo-Fractionated Radiotherapy in Breast Cancer (HYPORT-B)

Breast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer

India
Institut Curie

Completed

Hyperfractionated Versus Conventionally Fractionated Radiotherapy in Standard Risk Medulloblastoma (SIOP-PNET-4)

Medulloblastoma

France
Hospital da Baleia

Unknown

Hypofractionated Versus Conventional Fractionation Radiotherapy

Breast Cancer | Radiation Toxicity
University of Michigan Rogel Cancer Center

Recruiting

Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])

Prostate Cancer

United States
Institut Cancerologie de l'Ouest

Recruiting

Multicentre Medical-economic Study Evaluating the Efficacy of Adding ZOlédronique Acid to STERéotaxique Radiotherapy in the Treatment of Vertebral Metastases (ZOSTER)

Vertebral Metastasis

France
Merck Sharp & Dohme LLC

Active, not recruiting

Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)

Head and Neck Neoplasms

United States, Australia, Austria, Belgium, Brazil, Canada, Colombia, Czechia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Poland, Spain, Taiwan, Turkey, United Kingdom
Amgen

Completed

Study of Addition of Panitumumab to Chemoradiation Therapy in Patients With Locally Advanced Head and Neck Cancer

Head and Neck Cancer | Squamous Cell Carcinoma
Rajiv Gandhi Cancer Institute & Research Center...
Varian, a Siemens Healthineers Company

Recruiting

Dose Escalation Using Hypoxia-adjusted Radiotherapy (DE-HyART)

Head and Neck Squamous Cell Carcinoma

India
Hospices Civils de Lyon

Completed

Hypofractionated Radiotherapy Versus Stereotactic Irradiation With Hyaluronic Acid (RPAH2)

Prostatic Adenocarcinoma

France
University of Wisconsin, Madison
National Cancer Institute (NCI)

Active, not recruiting

Improving Pulmonary Function Following Radiation Therapy

Non-Small Cell Lung Cancer

United States
Institut du Cancer de Montpellier - Val d'Aurelle

Active, not recruiting

Evaluation of Late Toxicity Following Intensity-Modulated Radiotherapy and Two Image-Guided Strategies With Corresponding Treatment Margins. (RCMIGI)

Prostate Cancer

France
Prof. Franciszek Lukaszczyk Memorial Oncology Center

Completed

FET-PET Directed Simultaneous In-field Boost for Primary GBM (dualFETboost)

Glioblastoma Multiforme

Poland
Danish Head and Neck Cancer Group
International Atomic Energy Agency; Danish Center for Interventional Research...

Terminated

IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and Neck (IAEA-HypoX)

Head and Neck Carcinoma

Egypt, Estonia, Pakistan, Slovenia
Peking Union Medical College Hospital

Recruiting

Moderately Hypofractionated Adaptive Radiotherapy for Cervical Cancer

Cervical Neoplasm | Radiotherapy; Adverse Effect | Adaptive Radiotherapy

China
University Health Network, Toronto

Recruiting

Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate Cancer (MOB-RT)

Prostate Cancer

Canada
Medical University of Graz

Recruiting

SBRT for Ventricular Arrhythmia

Ventricular Arrythmia

Austria
University Ghent

Completed

Whole Breast + Lymph Node Irradiation: Prone Compared to Supine Position in 15 or 5 Fractions (PRO-SURF)

Breast Neoplasms | Lymph Node Metastases | Radiotherapy

Belgium
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Phase II Study of Moderate-dose Hypofractionated RT Combined With Tislelizumab for HCC With Diffuse Tumor Thrombosis

Hepatocellular Carcinoma | Radiotherapy | Tislelizumab | Tumor Thrombosis

China
Sheba Medical Center
European Union

Unknown

Treatment of Recurrent Brain Tumors: Metabolic Manipulation Combined With Radiotherapy (SMC 0712-13)

Brain Neoplasms

Israel
Medical College of Wisconsin

Withdrawn

Radiation Therapy With Sorafenib for TACE-Resistant Hepatocellular Carcinoma

Hepatocellular Carcinoma | Liver Cancer | Hepatoma | Hepatocellular Cancer

United States
Cancer Institute and Hospital, Chinese Academy...
Beijing Jishuitan Hospital

Recruiting

Preoperative Moderately Fractionated IMRT for Locally Extremity or Trunk Sarcoma

Soft Tissue Sarcoma

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis

Hepatocellular Carcinoma | Radiotherapy | Pembrolizumab | Tumor Thrombosis

China
Dr. Edward Chow

Completed

Prospective Study of Palonosetron in Radiation Induced Nausea and Vomiting (RINV)

Nausea | Vomiting

Canada
Virginia Commonwealth University
National Cancer Institute (NCI)

Completed

Neoadjuvant Chemotherapy Followed by Radiation Therapy and Gemcitabine/Sorafenib/Vorinostat in Pancreatic Cancer

Pancreatic Adenocarcinoma | Recurrent Pancreatic Carcinoma | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer

United States
Fertilitetscentrum AB
Vitrolife

Completed

Comparisons of Human Embryonic Development Using Single Medium With and Without the Addition of Antioxidants

Blastocyst | Human | Antioxidants | Culture Media | Embryo

Sweden

Search clinical trials for: Moderately-Hypo-fractionation Radiotherapy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations